Anixa Biosciences CEO Amit Kumar acquires 5,000 common shares valued at $17,350
Reuters2026/08/03 12:46- Anixa Biosciences CEO Amit Kumar bought 5,000 common shares in an open-market purchase at $3.47 per share.
- The purchase lifted his direct beneficial ownership to 657,000 common shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The first major "exam" after the Cook era! Morgan Stanley: Apple's (AAPL.US) autumn launch event is the most important in ten years; the first foldable iPhone may spark a new wave of growth
Morgan Stanley analysts stated that Apple's upcoming "Surprise and Shine" autumn product launch event on September 9 may become the company's most important product release in nearly a decade.

10-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - Germany vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations